Gary Guthart - Intuitive Surgical CEO and President and Director
| ISRG Stock | USD 375.01 0.00 0.00% |
CEO
Dr. Gary S. Guthart, Ph.D., is President, Chief Executive Officer, Director of the Company. In July 2007 since 2010.
| Age | 58 |
| Tenure | 14 years |
| Address | 1020 Kifer Road, Sunnyvale, CA, United States, 94086-5304 |
| Phone | 408 523 2100 |
| Web | https://www.intuitive.com |
Intuitive Surgical Management Efficiency
The company has return on total asset (ROA) of 0.08 % which means that it generated a profit of $0.08 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1582 %, meaning that it created $0.1582 on every $100 dollars invested by stockholders. Intuitive Surgical's management efficiency ratios could be used to measure how well Intuitive Surgical manages its routine affairs as well as how well it operates its assets and liabilities. The Intuitive Surgical's current Return On Tangible Assets is estimated to increase to 0.13. The Intuitive Surgical's current Return On Capital Employed is estimated to increase to 0.13. At this time, Intuitive Surgical's Other Current Assets are most likely to increase significantly in the upcoming years. The Intuitive Surgical's current Total Current Assets is estimated to increase to about 8.3 B, while Net Tangible Assets are projected to decrease to roughly 5.9 B.Similar Executives
| Found 13 records | CEO Age | ||
| Erik Holmlin | Bionano Genomics | 49 | |
| Robert Weiss | The Cooper Companies | 74 | |
| Devdatt Kurdikar | Embecta Corp | 56 | |
| Harrison Gross | Innovative Eyewear | 31 | |
| Eric Green | West Pharmaceutical Services | 54 | |
| Paul Remmell | The Cooper Companies | 58 | |
| Anthony Hunt | Repligen | 60 | |
| R Holmlin | Bionano Genomics | 49 | |
| Albert White | The Cooper Companies | 51 | |
| Jay Rosengarten | Innovative Eyewear | 64 | |
| Michael Farrell | ResMed Inc | 48 | |
| Albert III | The Cooper Companies | 54 | |
| Adam Levy | Nexgel Inc | 61 | |
Management Performance
| Return On Equity | 0.16 | ||||
| Return On Asset | 0.08 |
Intuitive Surgical Leadership Team
Elected by the shareholders, the Intuitive Surgical's board of directors comprises two types of representatives: Intuitive Surgical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Intuitive. The board's role is to monitor Intuitive Surgical's management team and ensure that shareholders' interests are well served. Intuitive Surgical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Intuitive Surgical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| David Rosa, Chief Commercial Officer and Executive VP | ||
| Mark Brosius, Senior Officer | ||
| Mark Rubash, Independent Director | ||
| Michael Friedman, Director | ||
| Gary Loeb, G Officer | ||
| Robert DeSantis, Executive Officer | ||
| Philip Kim, Head Relations | ||
| Keith Leonard, Director | ||
| Ian Purdy, Senior Assurance | ||
| Julian Nikolchev, Sr Strategy | ||
| Gillian EdD, Senior ServicesWorldwide | ||
| Jamie Samath, Principal Accounting Officer, VP and Corporate Controller | ||
| Gary JD, General VP | ||
| Amal Johnson, Independent Director | ||
| Craig Barratt, Independent Director | ||
| Eric Halvorson, Independent Director | ||
| Lonnie Smith, Chairman and Executive Officer | ||
| Jami Nachtsheim, Independent Director | ||
| Gary Guthart, CEO and President and Director | ||
| Marc Bland, GM VP | ||
| Alan Levy, Independent Director | ||
| Don Kania, Director | ||
| Myriam Curet, Senior Vice President Chief Medical Officer | ||
| Mark Meltzer, Chief Compliance Officer, Sr. VP and General Counsel | ||
| Colin Morales, Senior Vice President - Manufacturing and Service Operations | ||
| MD FACS, Executive Officer | ||
| Glenn Vavoso, Senior APAC | ||
| Salvatore Brogna, Executive VP of Product Operations | ||
| Brian Miller, Executive Officer | ||
| George Stalk, Independent Director | ||
| Amy Ladd, Director | ||
| Henry Charlton, Senior Officer | ||
| Fredrik Widman, Principal VP | ||
| Marshall Mohr, Executive Services | ||
| Christopher Carlson, Corporate Research |
Intuitive Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Intuitive Surgical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.16 | ||||
| Return On Asset | 0.08 | ||||
| Profit Margin | 0.27 % | ||||
| Operating Margin | 0.25 % | ||||
| Current Valuation | 129.04 B | ||||
| Shares Outstanding | 354.71 M | ||||
| Shares Owned By Insiders | 0.53 % | ||||
| Shares Owned By Institutions | 88.20 % | ||||
| Number Of Shares Shorted | 3.41 M | ||||
| Price To Earning | 69.96 X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Intuitive Surgical. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. For more detail on how to invest in Intuitive Stock please use our How to Invest in Intuitive Surgical guide.You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Complementary Tools for Intuitive Stock analysis
When running Intuitive Surgical's price analysis, check to measure Intuitive Surgical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Intuitive Surgical is operating at the current time. Most of Intuitive Surgical's value examination focuses on studying past and present price action to predict the probability of Intuitive Surgical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Intuitive Surgical's price. Additionally, you may evaluate how the addition of Intuitive Surgical to your portfolios can decrease your overall portfolio volatility.
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |
Is Intuitive Surgical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Intuitive Surgical. If investors know Intuitive will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Intuitive Surgical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.51 | Earnings Share 5.54 | Revenue Per Share 20.79 | Quarterly Revenue Growth 0.115 | Return On Assets 0.08 |
The market value of Intuitive Surgical is measured differently than its book value, which is the value of Intuitive that is recorded on the company's balance sheet. Investors also form their own opinion of Intuitive Surgical's value that differs from its market value or its book value, called intrinsic value, which is Intuitive Surgical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Intuitive Surgical's market value can be influenced by many factors that don't directly affect Intuitive Surgical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Intuitive Surgical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Intuitive Surgical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Intuitive Surgical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.